PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia

Ariës I.M., Bodaar K., Karim S.A., Chonghaile T.N., Hinze L., Burns M.A., Pfirrmann M., Degar J., Landrigan J.T., Balbach S., Peirs S., Menten B., Isenhart R., Stevenson K.E., Neuberg D.S., Devidas M., Loh M.L., Hunger S.P., Teachey D.T., Rabin K.R., Winter S.S., Dunsmore K.P., Wood B.L., Silverman L.B., Sallan S.E., Van Vlierberghe P., Orkin S.H., Knoechel B., Letai A.G., Gutierrez A

Research article (journal) | Peer reviewed

Details about the publication

JournalJournal of Experimental Medicine (J Exp Med)
Volume215
Page range3094-3114
StatusPublished
Release year2018
Language in which the publication is writtenEnglish
DOI10.1084/jem.20180570
Link to the full texthttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30404791/
KeywordsLeukemia; ETP-ALL; EZH2; PRC2

Authors from the University of Münster

Balbach, Sebastian
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)